CLDF Title
Home | Contact Us | Bookmark
    HCC   HE   HRS   NASH   PBC   THROMBOCYTOPENIA  
Centers of Educational Expertise  
Live CME Meetings Webcasts Slide Library Abstract Library CLDF 2019 Year in Review Conference Highlights
 
About CLDF | Mission Statement
The Chronic Liver Disease Foundation (CLDF) is a global nonprofit 501(c)(3) organization of leading hepatology specialists committed to raising awareness of the effects of chronic liver disease and sharing the latest insights with the healthcare community and patients.
Overview
The foundation's goal is to provide health professionals with the most current education and information on CLD.
 
Educational programs are designed so physicians, nurses, nurse practitioners, physician assistants, and pharmacists have information about the latest medical developments and their implications for patient management. Information is drawn from academia, medical societies, government health agencies, and the pharmaceutical industry, and is integrated into balanced, up-to-date educational programs and materials for health professionals.
 
The Chronic Liver Disease Foundation provides education to the medical community concerning a disease that affects an estimated 40 million people in the United States.
 
The most common types of CLD in the United States include nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, chronic hepatitis C, alcoholic liver disease, chronic hepatitis B, and hemochromatosis.
 
For all age groups, CLD was the 12th leading cause of death in the year 2000, accounting for more than 25,000 deaths. In the 45 to 54 age group, CLD and cirrhosis were the 4th leading cause of death in males, and the 6th leading cause of death in females.
 
More than 17,000 patients are currently on the liver transplant waiting list, yet just over 5000 patients receive liver transplants each year.
 
New therapies continue to evolve in the treatment of CLD. New molecular testing techniques aid in the detection and therapeutic monitoring of liver disease. Recombinant vaccines have been developed for 2 common types of hepatitis. And, in those cases where liver disease has progressed to a point where treatment is no longer effective, liver transplant has become a more viable option, in most instances, than it was just a decade ago.
 
 
 
                               
 
HEPATITIS
HBV
HCV
HDV
 
 
HCC
Slide Library
Abstract Library
 
HE
Webcasts
Slide Library
Abstract Library
 
HRS
Webcasts
Slide Library
Abstract Library
 
NASH
Webcasts
Slide Library
Abstract Library
 
 
PBC
Webcasts
Slide Library
Abstract Library
 
 
THROMBOCYTOPENIA
Webcasts
Slide Library
   
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors/Faculty
2019 GI Fellow Board of Advisors
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Hepatology
Substance Use Disorder
             
CLDF Follow Us
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2020 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.